ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 72 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $44,371,000 | -27.0% | 2,133,222 | +15.0% | 0.01% | -33.3% |
| Q3 2016 | $60,787,000 | +38.8% | 1,854,944 | +5.7% | 0.01% | +20.0% |
| Q2 2016 | $43,810,000 | +57.4% | 1,754,513 | +54.3% | 0.01% | +66.7% |
| Q1 2016 | $27,841,000 | -22.7% | 1,136,823 | +4.2% | 0.01% | -25.0% |
| Q4 2015 | $36,033,000 | -6.3% | 1,090,915 | -7.0% | 0.01% | -20.0% |
| Q3 2015 | $38,449,000 | -25.8% | 1,173,654 | +19.9% | 0.01% | -16.7% |
| Q2 2015 | $51,838,000 | +138.0% | 978,637 | +29.7% | 0.01% | +140.0% |
| Q1 2015 | $21,777,000 | +28.3% | 754,562 | +29.3% | 0.01% | +25.0% |
| Q4 2014 | $16,976,000 | +608.2% | 583,582 | +208.7% | 0.00% | +300.0% |
| Q3 2014 | $2,397,000 | -39.3% | 189,069 | -4.0% | 0.00% | 0.0% |
| Q2 2014 | $3,952,000 | – | 196,908 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
| Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
| PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
| Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
| Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
| PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
| Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
| Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |